Axsome (AXSM) Net Margin

Symbol and logo of brand Axsome Therapeutics (AXSM)

Axsome Therapeutics (AXSM) is aggressively expanding its presence in the neurological clinic segment, increasing the sales of new medications. The success of the antidepressant Auvelity and the completion of Alzheimer's drug trials are driving the stock's upward momentum. A diversified portfolio of innovative molecules minimizes patent risks. The net margin of core operations demonstrates profitability dynamics, where -18.20 represents the current level of the metric.

Axsome Therapeutics (AXSM) - Net Sales Margin from 07/04/2022 to 11/19/2026

Analytical breakdowns for Axsome Therapeutics

- share price and expert price forecast:
Initial company analysis:Axsome Therapeutics, AXSM
Flagship merchandise of Axsome Corp

Investors are assessing the resilience of Axsome Therapeutics (AXSM) through its net profit margin, which determines the volume of real income after covering all operating expenses. By analyzing the net profit margin, one can see how the costs of hiring commercial personnel while maintaining the scientific staff impact the overall business efficiency and the fundamental value of the shares.

Competitor analysis for Axsome Therapeutics

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Net Sales Margin|ACAD: Net Profit Rate|Net Sales Margin XENE|Net Sales Margin vikingtherapeutics.com (VKTX)|Net Margin Supernus SUPN|Net Profit Rate CPRX|denalitherapeutics.com - Net Sales Margin|Company Sales Margin Harmony Pharma HRMY|BHVN: Net Sales Margin|Net Margin Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Net Sales Margin|Net Return on Sales PRAX (Praxis Medicines)|Net Margin Anavex Life Sciences (AVXL)|Net Margin CBLL (CeriBell EEG)|Net Sales Margin PRTA (Prothena Corp)|alector.com (ALEC) - Net Margin|ANNX: Return on Sales by Net Profit|Net Margin Omeros|NGNE: Net Sales Margin|Return on Sales by Net Profit AC Immune|Return on Sales by Net Profit VYGR|Net Return on Sales NMRA (neumoratx.com)|Return on Sales by Net Profit SCLX (Scilex Holding Company, Inc.)|Net Margin TVGN (Tevogen Bio)|Net Margin Alpha Cognition ACOG|CGTX - Return on Sales by Net Profit|IKT - Net Margin|SAVA: Net Margin|Assertio Therapeutics (ASRT) - Net Margin|Net Margin Coya Therapeutics Inc (COYA)|Net Margin Vistagen|Net Return on Sales OVID (ovidrx.com)|Net Margin Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Net Margin|Alterity Therapeutics Ltd. - Return on Sales by Net Profit|CLNN - Return on Sales by Net Profit|PEPG - Net Margin|Company Sales Margin jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Net Margin|ANVS (Annovis Bio, Inc.) - Net Margin|Net Margin gracetx.com|Net Sales Margin Firefly Neuroscience, Inc.|Net Margin ANEW Medical (KLTO)|NRSN - Net Margin|Net Sales Margin RVPH (Reviva Pharmaceuticals Holdings Inc.)|Company Net Profitability MTVA (metaviatx.com)|NeurAxis Inc. - Net Sales Margin|Company Sales Margin heliusmedical.com HSDT|PASG: Net Sales Margin|Neuphoria - Net Profit Rate|Return on Sales by Net Profit NERV|ATHA: Net Profit Rate|Net Margin Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Net Profit Rate|Net Sales Margin CYCN (cyclerion.com)|Net Profitability Margin Protagenic|KTTA: Return on Sales by Net Profit|Net Profit Rate CRGT (cortigent.com)|ATXI: Net Sales Margin|BCLI (BrainStorm Cell Therapeutics) - Net Margin|CARA (Cara Therapeutics Inc.) - Net Sales Margin|Net Margin CHRO|Return on Sales by Net Profit ELYM (Eliem Therapeutics)|Net Margin ITCI (Intra-Cellular Therapies Inc.)|Net Sales Margin LBPH (Longboard Pharma)|Net Sales Margin Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Net Sales Margin|Net Profit Rate NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Return on Sales by Net Profit|Net Return on Sales SNPX|Return on Sales by Net Profit TRVN|Net Margin VIGL|Net Sales Margin WENA|Company Sales Margin Cerevel